The therapeutic potential of C-C chemokine receptor antagonists in nonalcoholic steatohepatitis

• Autores principales: Michael Doulberis (Autor), Kasiani Papadimitriou (Autor), Apostolis Papaefthymiou (Autor), Jannis Kountouras (Autor), Stergios A. Polyzos (Autor)
• Formato: Libro
• Publicado: Open Exploration Publishing Inc., 2020-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Pooled prevalence of nonalcoholic fatty liver disease (NAFLD) globally is about 25%. Nonalcoholic steatohepatitis (NASH) with advanced fibrosis has been linked with substantial morbidity and mortality, without having to-date any licensed treatment. C-C chemokine receptor (CCR) antagonists have been...